-
- Target See all Minute (2) 31A (M(2)31A) products
- Minute (2) 31A (M(2)31A)
- Purity
- > 95 %
-
- Restrictions
- For Research Use only
-
- Storage
- -20 °C
-
-
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation." in: Vaccine, Vol. 32, Issue 29, pp. 3664-9, (2014) (PubMed).
: "
-
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation." in: Vaccine, Vol. 32, Issue 29, pp. 3664-9, (2014) (PubMed).
-
- Target
- Minute (2) 31A (M(2)31A)
- Target Type
- Influenza Protein
- Background
- M2 is the third integral membrane protein of influenza A. M2e, which consists of the 23 extracellular residues of M2, has been remarkably conserved in all human influenza A strains. M2e is a valid and versatile vaccine candidate and may protect against any strain of human influenza A.
-